| Serial Number | 86698323 |
| Word Mark | MICROBAC |
| Filing Date | Monday, July 20, 2015 |
| Status | 701 - SECTION 8 - ACCEPTED |
| Status Date | Monday, July 3, 2023 |
| Registration Number | 4986679 |
| Registration Date | Tuesday, June 28, 2016 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 12, 2016 |
| Certificate of Correction for Registration | In the statement, line 19, "containing microorganisms and cultures of microorganisms" should be should be inserted after "products". |
| Goods and Services | Micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; Supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; Supplements, namely, dietary supplements for medical use and baby food, all the above containing liquid, solid, dried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposes, all the foregoing being for medical and veterinary use only |
| Pseudo Mark | MICRO BACK |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 24, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PROBIOTICAL S.P.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | NOVARA 28100 IT |
| Party Name | PROBIOTICAL S.P.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | 28100 NOVARA IT |
| Party Name | PROBIOTICAL S.P.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | 28100 NOVARA IT |
| Event Date | Event Description |
| Monday, July 3, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Monday, July 3, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| Tuesday, June 20, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, February 7, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, February 7, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, February 7, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, December 27, 2022 | TEAS SECTION 8 RECEIVED |
| Monday, June 28, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Monday, October 31, 2016 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| Monday, August 1, 2016 | SEC 7 REQUEST FILED |
| Monday, October 31, 2016 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, August 1, 2016 | PAPER RECEIVED |
| Tuesday, June 28, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 12, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 12, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 23, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, March 9, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, March 2, 2016 | ASSIGNED TO LIE |
| Wednesday, March 2, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 2, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 2, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 2, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 2, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, January 28, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 28, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 26, 2016 | ASSIGNED TO LIE |
| Wednesday, January 13, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 30, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 30, 2015 | NON-FINAL ACTION E-MAILED |
| Friday, October 30, 2015 | NON-FINAL ACTION WRITTEN |
| Thursday, October 29, 2015 | ASSIGNED TO EXAMINER |
| Saturday, July 25, 2015 | NOTICE OF PSEUDO MARK E-MAILED |
| Friday, July 24, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 23, 2015 | NEW APPLICATION ENTERED |